Skip to main content
Livermore
Livermore
ZHEN

Osage University Partners III, LP's Form 4 filing

Mobia Medical, Inc. (MOBI) · filed May 12, 2026

Accession no.
0001193125-26-219510
Filed
May 12, 2026, 4:17 PM ET
Trade date
Jan 30-May 11, 2026
Filing delay
102 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 6 non-derivative transactions and 7 derivative transactions. Open-market purchases total $8.00M. It was filed 102 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Osage University Partners III, LPCIK 000174303610% Owner
Osage University GP III, LLCCIK 000188047610% Owner
Osage University Partners IV, LPCIK 000190148310% Owner
Osage University GP IV, LLCCIK 000213422210% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 11, 2026Common StockCConversionAcquired+284,324–F1–284,324IndirectDuplicate filing
May 11, 2026Common StockCConversionAcquired+264,746–F1–264,746IndirectDuplicate filing
May 11, 2026Common StockCConversionAcquired+1,455,726–F4–1,740,050IndirectDuplicate filing
May 11, 2026Common StockCConversionAcquired+872,770–F4–1,137,516IndirectDuplicate filing
May 11, 2026Common StockPPurchaseAcquired+266,666$15.00+$3,999,9902,006,716IndirectDuplicate filing
May 11, 2026Common StockPPurchaseAcquired+266,667$15.00+$4,000,0051,404,183IndirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 30, 2026Common StockAGrant or awardAcquired+284,324$3,411,892.25+$11,641,008,725,610.063,411,892.25IndirectPrice outlierDuplicate filing
Jan 30, 2026Common StockAGrant or awardAcquired+264,746$3,176,955.03+$10,093,043,262,642.33,176,955.03IndirectPrice outlierDuplicate filing
May 11, 2026Common StockCConversionDisposed−284,324–F1–0IndirectDuplicate filing
May 11, 2026Common StockCConversionDisposed−264,746–F1–0IndirectDuplicate filing
May 11, 2026Common StockCConversionDisposed−1,128,438–F4–0IndirectDuplicate filing
May 11, 2026Common StockCConversionDisposed−327,288–F4–0IndirectDuplicate filing
May 11, 2026Common StockCConversionDisposed−872,770–F4–0IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

F4

Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms.

Referenced by the price of 2 transactions in Table I and 3 transactions in Table II.

Remarks

William Harrington is a member of the Issuer's board of directors and files separate Section 16 reports.

Read the full filing on SEC EDGAR (opens in a new tab)